Spots Global Cancer Trial Database for homologous recombination repair (hr)
Every month we try and update this database with for homologous recombination repair (hr) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency | NCT06120972 | Ovarian Cancer | Olaparib tablet | 18 Years - | University of Pittsburgh | |
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency | NCT06120972 | Ovarian Cancer | Olaparib tablet | 18 Years - | University of Pittsburgh |